Enfusion (Enfusion) Net Change in Cash : $-26.9 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Enfusion Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Enfusion's Net Change in Cash for the three months ended in Dec. 2023 was $4.0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was $-26.9 Mil.

Enfusion Net Change in Cash Historical Data

The historical data trend for Enfusion's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enfusion Net Change in Cash Chart

Enfusion Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

0.25

8.04

50.43

-1.82

-26.94

Enfusion Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial											-1.00	-7.95	-26.83	3.88	3.95

Enfusion Net Change in Cash Calculation

Enfusion's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	25.634	+	-9.671	+	-43.083	+	0.179
	=	-26.9

Enfusion's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 6.586 + -2.295 + -0.579 + 0.24

= 4.0

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enfusion Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Enfusion's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Enfusion (Enfusion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Enfusion Inc (NYSE:ENFN) » Definitions » Net Change in Cash

Comparable Companies

BIGC DBD RSKD MTWO CRNC MTTR KARO EB PUBM WKME CRM XTER:SAP INTU NOW UBER CDNS SHOP WDAY XPAR:DSY ROP

Traded in Other Exchanges

N/A

Address

125 South Clark Street, Suite 750, Chicago, IL, USA, 60603

Website

https://www.enfusion.com

Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.

Executives

Deirdre Somers director C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO IL 60603

Bradley Herring officer: Chief Financial Officer C/O SHIFT4 PAYMENTS, INC., 2202 N. IRVING STREET, ALLENTOWN PA 16109

Oleg Movchan director, 10 percent owner C/O ENFUSION INC., 125 SOUTH CLARK ST. STE 750, CHICAGO IL 60603

Bronwen Bastone officer: Chief People Officer C/O ENFUSION, INC., 125 SOUTH CLARK STREET SUITE 750, CHICAGO IL 60603

Stephen Malherbe 10 percent owner C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO IL 60603

Dan Groman officer: Chief Technology Officer C/O ENFUSION INC., 125 SOUTH CLARK STREET STE. 750, CHICAGO IL 60603

Tarek Hammoud 10 percent owner C/O ENFUSION INC., 125 SOUTH CLARK ST. STE. 750, CHICAGO IL 60603

Ftv Investment Holdings, L.p. 10 percent owner 601 CALIFORNIA STREET, FLOOR 19, SAN FRANCISCO CA 94108

Michael Spellacy director 399 PARK AVENUE, NEW YORK NY 10022

Quiet Light Securities, Llc 10 percent owner 70 WEST MADISON, SUITE 1675, CHICAGO IL 60602

Steven M. Bachert officer: Chief Revenue Officer C/O ENFUSION INC., 125 SOUTH CLARK ST., STE 750, CHIGAGO IL 60603

Lra Ventures, Llc 10 percent owner C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO IL 60603

Hillhouse Investment Management, Ltd. 10 percent owner OFFICE #122, WINDWARD 3 BUILDING, REGATTA OFFICE PARK, WEST BAY ROAD, GRAND CAYMAN E9 KY1-9006

Roy Luo director 394 PACIFIC AVENUE, 2ND FLOOR, SAN FRANCISCO CA 94111

Iconiq Strategic Partners V-b, L.p. 10 percent owner 394 PACIFIC AVENUE, SECOND FLOOR, SAN FRANCISCO CA 94111

Enfusion (Enfusion) Headlines

From GuruFocus

Global SaaS Leader Zone & Co Appoints Seasoned FinTech Exec Thomas Kim as New CEO
By PRNewswire PRNewswire • 05-02-2023

Enfusion Appoints Oleg Movchan Interim Chief Executive Officer
By Business Wire Business Wire • 08-22-2022

Enfusion Announces Third Quarter 2022 Earnings Release Date
By Business Wire Business Wire • 10-21-2022

Enfusion Announces Date of Third Quarter 2023 Results
By Business Wire • 10-19-2023

Enfusion Announces First Quarter 2023 Results
By Business Wire Business Wire • 05-09-2023

Enfusion Names Oleg Movchan as Chief Executive Officer
By Business Wire Business Wire • 12-22-2022

Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director
By Business Wire Business Wire • 01-11-2023

Enfusion Elevates Valeria Gutowski to Chief Accounting Officer
By Business Wire • 01-18-2024

Enfusion Announces Date of First Quarter 2023 Results
By Business Wire Business Wire • 04-20-2023

CORRECTING and REPLACING Enfusion Continues to Expand into New Client Segments Through the Launch of Enfusion Express OEMS
By Business Wire Business Wire • 07-26-2022

Deirdre Somers	director	C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO IL 60603
Bradley Herring	officer: Chief Financial Officer	C/O SHIFT4 PAYMENTS, INC., 2202 N. IRVING STREET, ALLENTOWN PA 16109
Oleg Movchan	director, 10 percent owner	C/O ENFUSION INC., 125 SOUTH CLARK ST. STE 750, CHICAGO IL 60603
Bronwen Bastone	officer: Chief People Officer	C/O ENFUSION, INC., 125 SOUTH CLARK STREET SUITE 750, CHICAGO IL 60603
Stephen Malherbe	10 percent owner	C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO IL 60603
Dan Groman	officer: Chief Technology Officer	C/O ENFUSION INC., 125 SOUTH CLARK STREET STE. 750, CHICAGO IL 60603
Tarek Hammoud	10 percent owner	C/O ENFUSION INC., 125 SOUTH CLARK ST. STE. 750, CHICAGO IL 60603
Ftv Investment Holdings, L.p.	10 percent owner	601 CALIFORNIA STREET, FLOOR 19, SAN FRANCISCO CA 94108
Michael Spellacy	director	399 PARK AVENUE, NEW YORK NY 10022
Quiet Light Securities, Llc	10 percent owner	70 WEST MADISON, SUITE 1675, CHICAGO IL 60602
Steven M. Bachert	officer: Chief Revenue Officer	C/O ENFUSION INC., 125 SOUTH CLARK ST., STE 750, CHIGAGO IL 60603
Lra Ventures, Llc	10 percent owner	C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO IL 60603
Hillhouse Investment Management, Ltd.	10 percent owner	OFFICE #122, WINDWARD 3 BUILDING, REGATTA OFFICE PARK, WEST BAY ROAD, GRAND CAYMAN E9 KY1-9006
Roy Luo	director	394 PACIFIC AVENUE, 2ND FLOOR, SAN FRANCISCO CA 94111
Iconiq Strategic Partners V-b, L.p.	10 percent owner	394 PACIFIC AVENUE, SECOND FLOOR, SAN FRANCISCO CA 94111